Recently IPOd Biofrontera surges 146% following Roth buy initiation; sees 660% upside

seekingalpha2021-11-25

Shares of Biofrontera (BFRI+147.1%) have skyrocketed today after Roth Capital initiated the stock with a buy rating and a $20 price target (~660% upside). Analyst Jonathan Aschoff says his rating and ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
12